A 2026 bullish stock list with brief long theses and catalysts for 32 US-listed equities.
ACN — LONG The author says Accenture is making strong progress with AI, with managed services up 10% year over year and better operating margins expected in fiscal 2026. That combination of AI-driven growth and margin improvement is the stated mechanism for further gains, which the author says technical indicators and volume/momentum support.
Accenture is making strong progress with AI, showing a 10% year-over-year increase in managed services and better operating margins expected in fiscal 2026.
ADP — LONG The author calls ADP a reliable performer with consistent earnings and dividends, setting up for about 31% total returns in 2026. The mechanism is steady growth plus an attractive entry point after recent market dips.
ADP is a reliable performer with consistent earnings and dividends, setting up for about 31% total returns in 2026 due to steady growth and an attractive entry point from recent market dips.
BIIB — LONG The author says Biogen’s pipeline is advancing, including EU approval for a high-dose version of Spinraza, which strengthens the positive outlook. Combined with stable earnings and a recent 9% stock rise, the author sees recovery potential.
Biogen’s pipeline is advancing, including EU approval for a high-dose version of Spinraza, which strengthens the positive outlook.
CHDN — LONG The author says Churchill Downs benefits from its strong brand and investments in luxury experiences like Derby suites, plus buybacks that cut outstanding shares by 30% over the past decade. Analysts expect a higher valuation from new track developments, which is the stated catalyst.
Churchill Downs benefits from its strong brand and investments in luxury experiences like Derby suites, along with share buybacks that have reduced outstanding shares by 30% over the past decade.
CNC — LONG The author says Centene appears undervalued at current multiples, with stable earnings and the possibility of trading at 14 times 2026 EPS. The stated risk is government-related, while margin improvements could shift sentiment positively.
Centene appears undervalued at current multiples, with stable earnings and the possibility of trading at 14 times 2026 earnings per share.
LIN — LONG The author says Linde has a backlog of $7 to $10 billion in long-term contracts supporting over 10% EPS growth. Analysts remain positive on its consistent expansion and long-term compounding ability.
Linde has a backlog of $7 to $10 billion in long-term contracts, supporting over 10% earnings per share growth.
MCK — LONG The author says McKesson seems undervalued by about 41% based on discounted cash flow analysis, with ongoing benefits from GLP-1 trends into 2026. Its strong performance over recent years indicates room for further progress.
McKesson seems undervalued by about 41% based on discounted cash flow analysis, with ongoing benefits from GLP-1 trends into 2026.
NOW — LONG The author says ServiceNow’s AI efforts could generate over $1 billion in annual recurring revenue by 2026, attracting hedge funds and positive analyst views. Despite a 28% decline, the author sees the setup as suggesting a possible rebound.
ServiceNow’s AI efforts could generate over $1 billion in annual recurring revenue by 2026, attracting hedge funds and positive analyst views.
PAYX — LONG The author says Paychex looks undervalued with expected revenue growth ahead. A partnership with PayPal enhances sentiment, and the author targets potential upside to $133 based on its recurring business model.
A partnership with PayPal enhances sentiment, targeting potential upside to $133 based on its recurring business model.
STLA — LONG The author says Stellantis has been upgraded to overweight, with leadership changes and $13 billion in U.S. investments aimed at sales recovery by 2026. The current dip is presented as a value opportunity.
Stellantis has been upgraded to overweight, with leadership changes and $13 billion in U.S. investments aimed at sales recovery by 2026.
UNH — LONG The author says UnitedHealth could return to all-time highs in 2026 through adjustments in care ratios. Undervaluation suggests upside to over $400 per share in positive scenarios.
UnitedHealth could return to all-time highs in 2026 through adjustments in care ratios, with undervaluation suggesting upside to over $400 per share in positive scenarios.
WIX — LONG The author says Wix’s AI-powered website builder and partnerships are driving growth. Its under $5 billion valuation offers asymmetric opportunities, and the author sees potential for expansion.
Wix’s AI-powered website builder and partnerships are driving growth, with its under $5 billion valuation offering asymmetric opportunities.
This Reddit post, published January 26, 2026, features u/batdog44 discussing ACN, ADP, BIIB, CHDN, CNC, LIN, MCK, NOW, PAYX, STLA, UNH, WIX. 12 trade ideas extracted by AI with direction and confidence scoring.
Speakers: u/batdog44 · Tickers: ACN, ADP, BIIB, CHDN, CNC, LIN, MCK, NOW, PAYX, STLA, UNH, WIX